Educational paper: formulation-related issues in pediatric clinical pharmacology

Area of Science:

• Pediatric Pharmacology
• Drug Development
• Biopharmaceutics

Background:

• Childhood physiological changes significantly impact drug pharmacokinetics, especially in early infancy.
• The importance of clinically relevant drug formulations and administration devices for pediatric use is often underestimated.
• The EU Paediatric Regulation (since 2007) mandates paediatric investigation plans, emphasizing age-appropriate dosage forms and administration methods.

Purpose of the Study:

• To highlight the critical relevance of formulation issues in pediatric drug development.
• To underscore the need for age-appropriate drug formulations and administration devices.
• To emphasize the importance of palatability, acceptability, and excipient safety in pediatric medicines.

Main Methods:

• Review of regulatory requirements (EU Paediatric Regulation).
• Discussion of pharmacokinetic and pharmacodynamic considerations in pediatric populations.
• Identification of research gaps in pediatric biopharmaceutics, including in vitro tools and bridging studies.

Main Results:

• Pediatric drug development has gained prominence, with a recognized need for suitable formulations.
• Regulatory bodies prioritize palatability, acceptability, and excipient safety for pediatric drug products.
• A significant gap exists in research concerning pediatric biopharmaceutics and associated methodologies.

Conclusions:

• Clinical pharmacologists must actively contribute to advancing pediatric drug formulation science.
• Further research into pediatric biopharmaceutics is essential for optimizing drug therapy in children.
• Addressing formulation challenges is key to improving the efficacy and safety of medicines for pediatric patients.